Local therapy with a complex of exogenous cytokines in patients with recurrent viral-bacterial infections of the lower genital tract
- Authors: Dikke G.B1, Sukhanov A.A2, Kukarskaya I.I2,3, Ostromensky V.V1
-
Affiliations:
- Academy of Medical Education n.a. F.I. Inozemtsev
- Perinatal Center, Tyumen
- Tyumen State Medical University
- Issue: Vol 28, No 6 (2021)
- Pages: 44-50
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/313163
- DOI: https://doi.org/10.18565/pharmateca.2021.6.44-50
- ID: 313163
Cite item
Abstract
Background. Researchers note an increase in the frequency of relapses of vaginal dysbiosis to 69-80% of observations within 12 months. Currently, information on the participation of cytokines in the implementation of the innate immune response of the mucous membranes of the female reproductive tract has been obtained. The use of immunodiagnostics and immunomodulatory therapy with exogenous cytokines can significantly improve treatment outcomes and relapse prevention.Objective. Evaluation of the effectiveness of therapy and the frequency of relapses in patients with recurrent infectious and inflammatory diseases of the lower genital tract of combined viral and bacterial etiology using various regimens of local immunomodulatory therapy. Methods. A prospective, randomized, comparative, parallel-group clinical study was conducted. 58 women with recurrent vaginal dys-biosis were examined. In group I (n=30), the drug Superlimph 25 U was used vaginally daily for 10 days, in group II (n=28) - 10 U for 20 days; both groups reseived etiotropic therapy with a combined broad-spectrum drug with antibacterial, antifungal and anti-inflammatory effects (1 vaginal tablet daily for 10 days). Microscopy of vaginal smears, real-time PCR, determination of blood serum cytokine levels (IL-1β, -2, -4, -6, -8, -10, tumor necrosis factor α, interferon γ - IFN-γ) were used.Results. Clinical recovery occurred in 90% (27/30; p<0.001) and 89% (25/28; p<0.001), respectively. Microbiological recovery according to microscopic examination was observed in 100% of patients in both groups (30/30 and 28/28; p<0.001). The frequency of HSV-2 virus shedding in group I decreased from 83% before treatment to 37% after it (p<0.001), as in group II - from 82 to 43%, respectively (p=0.002), p=0.63 - between groups after treatment. Before treatment, the level of all cytokines, except IFN-γ, was higher than the reference values; after treatment, their values decreased in both groups (p<0.001). During 12 months after treatment, in group I, high cytokine levels persisted in 13.3% and a relapse of vaginal dysbiosis was detected in 6.7% (2/30) of patients, in group II it was not observed (p=0.44). No side effects were observed during treatment. Adherence and acceptability were 100% in both groups.Conclusion. Recurrent combined viral-bacterial vaginal infections are accompanied by an imbalance of pro- and anti-inflammatory cytokines. Treatment using the drug Superlimph (25 IU for 10 and 10 IU 20 days) in combination with etiotropic therapy has comparable clinical and microbiological efficacy, prevents recurrence of infections, with a preferable course of 20 days with a dose of 10 IU
Keywords
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
G. B Dikke
Academy of Medical Education n.a. F.I. Inozemtsev
Email: galadikke@yandex.ru
Dr. Sci. (Med.), Associate Professor, Professor at the Department of Obstetrics and Gynecology with a Course in Reproductive Medicine
A. A Sukhanov
Perinatal Center, Tyumen
I. I Kukarskaya
Perinatal Center, Tyumen; Tyumen State Medical University
V. V Ostromensky
Academy of Medical Education n.a. F.I. Inozemtsev
References
- Sobel J.D., Kaur N., Woznicki N.A., et al. Prognostic Indicators of Recurrence of Bacterial Vaginosis. J Clin Microbiol. 2019;57(5):e00227-19. doi: 10.1128/JCM.00227-19.
- Макаров И.О., Гомберг М.А., Боровкова Е.И. и др. Бактериальный вагиноз: состояние изученности проблемы. Акушерство, гинекология и репродукция. 2013;7(4):20-4.
- Прилепская В.Н., Уруймагова А.Т., Иванова А.А. Клинические и лабораторные особенности рецидивирующих вульвовагинитов и вагинозов. Возможности эффективной терапии. Гинекология. 2020;22(5):76-80
- Ike A.C., Onu C.J., Ononugbo C.M., et al. Immune Response to Herpes Simplex Virus Infection and Vaccine Development. Vaccines (Basel). 2020;8(2):302. doi: 10.3390/vaccines8020302
- Дикке Г.Б, Суханов А.А., Остроменский В.В. Иммуноопосредованные механизмы воспалительного ответа при сочетанных инфекциях нижнего отдела полового тракта у женщин. Акушерство, гинекология и репродукция. 2021;4
- Kurt-Jones E.A., Orzalli M.H., Knipe D.M. Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease. Adv Anat Embryol Cell Biol. 2017;223:49-75. doi: 10.1007/978-3-319-53168-7_3
- Дикке Г.Б., Остроменский В.В. Нарушение иммунного статуса при хроническом эндометрите и опыт его коррекции посредством локальной цитокинотерапии. Акушерство и гинекология. 2019;9:139-46
- Дикке Г.Б. Полимикробные ассоциации в этиологии воспалительных заболеваний половых органов у женщин. Акушерство и гинекология. 2017;6:151-58
- Мамчур В.И., Дронов С.Н. Тержинан глазами фармаколога: инновационный подход к терапии вагинитов различного генеза. Медицинские аспекты женского здоровья. 2015;9(95):50-7
- Esber А., at al. Risk of bacterial vaginosis among women with herpes simplex virus type 2 infection: A Systematic Review and Meta-analysis. J Infect Dis. 2015;212(1):8-17. doi: 10.1093/infdis/ jiv017
- Xiong Y.Q., Mo Y., Luo Xiong Q.M., ot al. The Risk of Human Papillomavirus infection for Spontaneous Abortion, Spontaneous Preterm Birth, and Pregnancy Rate of Assisted Reproductive Technologies: A Systematic Review and MetaAnalysis. Gynecol Obstet Invest. 2018;83(5):417 27. doi: 10.1159/000482008
- Pereira N., et al. Human papillomavirus infection, infertility, and assisted reproductive outcomes. J Pathog. 2015;2015:578423
- Nason M.C., Patel E.U., Kirkpatrick A.R., et al. Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral Treatment. Open Forum Infect Dis. 2016;3(2):ofw073. doi: 10.1093/ofid/ofw073
- Гоциридзе К.Э., Кинтрая Н.П. Диагностическая значимость натуральных киллеров периферической крови при привычном невынашивании беременности. Акушерство, гинекология и репродукция. 2021;15(1):61-9
- Cheng S.-C., Chai L.Y.A., Joosten L.A.B., et al. Candida albicans releases soluble factors that potentiate cytokine production by human cells through a protease-activated receptor 1- and 2-independent pathway. Infect Immun. 2009;78(1):393-99. doi: 10.1128/IAI.01041-09.
- Marconi C., Donders G.G.G., Bellen G., et al. Sialidase activity in aerobic vaginitis is equal to levels during bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol. 2013;167:205-9. doi: 10.1016/j.ejogrb.2012.12.003.
- Рахматуллаева М.М. Уровень провоспалительных цитокинов в диагностике бактериального вагиноза. Фундаментальные и практические вопросы иммунологии и инфектологии. 2018;2:3-7.
- Hemalatha R., Ramalaxmi B.A., KrishnaSwetha G., et al. Cervicovaginal inflammatory cytokines and sphingomyelinase in women with and without bacterial vaginosis. Am J Med Sci. 2012;344( 1):35-9. Doi: 10.1097/ MAJ.0b013e318235597b
- Hedge S.R., Barrientes F, Desmond R.A., Schwebke J.R. Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Diseases. 2006;193(4):556-62. doi: 10.1086/499824
- Kremleva E.A., Sgibnev A.V. Proinflammatory cytokines as regulators of vaginal microbiota. Bull Exp Biol Med. 2016;162:75-8. Doi: 10.1007/ s10517-016-3549-1
- Павленко В.И. Диагностика и лечение иммунодефицитных состояний: учебное пособие. Благовещенск, 2017. 232 с
Supplementary files
![](/img/style/loading.gif)